Christina Galbraith

MasterSwitch Bio

BIOGRAPHY

Christina Galbraith is the Chief Operating Officer and co-founder of MasterSwitch Bio, a biotech company developing mRNA-LNP therapeutics to treat advanced degenerative diseases, including end-stage liver disease and cirrhosis. She previously served as a consultant head of business development for INSERM in France, Boston Children's Hospital, Massachusetts Eye and Ear, and Massachusetts General Hospital to advance gene-based therapies.

Christina is a published science journalist with Newsweek, Futurism, and Technomy, bringing a unique combination of scientific communication and commercial leadership to advancing mRNA therapeutic development.